REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY

人血小板凝血酶原活性的调节

• 批准号: 6202327
• 负责人: Paula Babiarz Tracy
• 金额: $ 25.4万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-29 至 2000-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6202327
• 关键词: antifibrinolytic agents; blood coagulation; calcium flux; chemical binding; clotting factor; coagulation factor V; coagulation factor X; enzyme activity; enzyme complex; fibrinogen receptors; fibrinolysis; human tissue; intermolecular interaction; membrane proteins; platelet activation; protein C; protein kinase C; protein structure function; prothrombin; receptor; receptor expression; thrombin; thrombosis

Thrombin generation at the human platelet surface is effected through the assembly and function of the enzymatic complex, Prothrombinase, consisting of a 1:1 stoichiometric, Ca/2+ complex of the cofactor factor Va and the serine protease factor Xa. Subsequent to platelet activation, released platelet factor V(a) and/or plasma-derived factor Va bind to the platelet membrane surface and in so doing form at least part of the receptor for factor Xa. Thus, several protein/protein and protein/membrane interactions dictate functional complex assembly. A goal of this research project is to define how platelets actively participate in and regulate complex assembly. Because platelets have been shown to express the factor Xa membrane receptor Effector Protease Receptor-1 (EPR-1) following agonist-induced activation, substantial effort will be placed on defining its role in, and regulation of, a functional Prothrombinase complex. The platelet's ability to regulate events critical for enzyme complex assembly subsequent to agonist-induced activation will be assessed as well, specifically as related to 1) functional EPR-1 expression and 2) expression of a platelet factor Va molecule resistant to activated protein C inactivation, and perhaps other proteases as well. Because thrombin once formed positively regulates Prothrombinase complex assembly and function through platelet activation, a second goal is to understand how thrombin interactions with platelet membrane proteins affect its function. Effort will be placed on defining and isolating the thrombin high affinity binding site which appears to render the thrombin molecule transiently inactive and delineating the relationship of glycoprotein Ib/IX to this site. Finally, the observation that both a thrombomodulin-like molecule constitutively expressed on the platelet membrane and platelet-derived factor Va inhibit fibrinolysis through a thrombin-dependent mechanism will be explored, especially as related to the recently identified Thrombin Activatable Fibrinolysis Inhibitor (TAFI). The ultimate goal of this research project is to define the mechanisms by which platelets actively regulate both the generation and function of thrombin at their membrane surface. Defining the cellular and molecular events which regulate thrombin production is fundamental to our overall understanding of the hemostatic and thrombotic processes.

凝血酶在人血小板表面的产生是通过 酶复合物凝血酶原酶的组装和功能， 的1：1化学计量的Ca/2+复合物的辅因子Va和 丝氨酸蛋白酶因子Xa。 血小板活化后，释放 血小板因子V（a）和/或血浆衍生因子Va与血小板结合 膜表面，并在这样做时形成受体的至少一部分， 因子Xa。 因此，几种蛋白质/蛋白质和蛋白质/膜 相互作用决定了功能复杂的组装。 这项研究的一个目标是 该项目旨在确定血小板如何积极参与和调节 复杂的装配。 因为血小板已经被证明表达该因子 Xa膜受体效应蛋白酶受体-1（EPR-1） 激动剂诱导的激活，大量的努力将放在定义 其在功能性凝血酶原酶复合物中的作用和调节。 的 血小板调节酶复合物组装关键事件的能力 也将评估激动剂诱导的激活之后， 特别是与1）功能性EPR-1表达和2） 抗活化蛋白的血小板因子Va分子的表达 C失活，也许还有其他蛋白酶。 因为凝血酶 一旦形成，就正向调节凝血酶原酶复合物组装， 第二个目标是了解如何通过血小板活化发挥作用， 凝血酶与血小板膜蛋白的相互作用影响其功能。 将努力定义和分离凝血酶高亲和力 似乎使凝血酶分子瞬时 无活性，并描绘了糖蛋白Ib/IX与此的关系 绝佳的价钱 最后，血栓调节蛋白样分子 在血小板膜上组成型表达， 因子Va通过凝血酶依赖性机制抑制纤维蛋白溶解， 特别是与最近发现的凝血酶有关的， 活化纤维蛋白溶解抑制剂（TAFI）。 这最终的目的 研究项目是确定血小板积极地 调节膜上凝血酶的产生和功能 面 定义调节细胞和分子的事件， 凝血酶的产生是我们全面了解 止血和血栓形成过程。